Clinical Trials Browser

Terminated × tisagenlecleucel × Clear all

NCT04161118 2023-05-06

TIGER-CTL019

Phase 2 Terminated

Lymphoma, Non-Hodgkin

NCT03876028 2023-01-31

Study of Tisagenlecleucel in Combination With Ibrutinib in r/r Diffuse Large B-cell Lymphoma Patients

Phase 1 Terminated

Lymphoma, Recurrence, Lymphoma, Large B-Cell, Diffuse